Unique biological markers in patients with mild Crohn’s disease uncovered

A new study led by researchers at Mount Sinai Health System has identified distinct biological signatures in patients with mild Crohn’s disease, offering a potential pathway toward more personalized and less aggressive treatment strategies.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup